Biomm Sa Stock Fundamentals
BIOM3 Stock | BRL 10.08 0.08 0.80% |
Biomm SA fundamentals help investors to digest information that contributes to Biomm SA's financial success or failures. It also enables traders to predict the movement of Biomm Stock. The fundamental analysis module provides a way to measure Biomm SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomm SA stock.
Biomm |
Biomm SA Company Operating Margin Analysis
Biomm SA's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biomm SA Operating Margin | (0.90) % |
Most of Biomm SA's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomm SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Biomm SA has an Operating Margin of -0.8961%. This is 97.45% lower than that of the Biotechnology sector and 99.2% lower than that of the Health Care industry. The operating margin for all Brazil stocks is 83.74% lower than that of the firm.
Biomm SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomm SA's current stock value. Our valuation model uses many indicators to compare Biomm SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomm SA competition to find correlations between indicators driving Biomm SA's intrinsic value. More Info.Biomm SA is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biomm SA's earnings, one of the primary drivers of an investment's value.Biomm Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomm SA's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomm SA could also be used in its relative valuation, which is a method of valuing Biomm SA by comparing valuation metrics of similar companies.Biomm SA is currently under evaluation in operating margin category among its peers.
Biomm Fundamentals
Return On Equity | -0.77 | |||
Return On Asset | -0.15 | |||
Profit Margin | (0.99) % | |||
Operating Margin | (0.90) % | |||
Current Valuation | 554.55 M | |||
Shares Outstanding | 81.29 M | |||
Shares Owned By Insiders | 52.30 % | |||
Shares Owned By Institutions | 30.21 % | |||
Price To Earning | (8.47) X | |||
Price To Book | 3.63 X | |||
Price To Sales | 4.40 X | |||
Revenue | 107.09 M | |||
Gross Profit | 26.93 M | |||
EBITDA | (53.76 M) | |||
Net Income | (80.26 M) | |||
Cash And Equivalents | 30.58 M | |||
Cash Per Share | 1.36 X | |||
Total Debt | 134.07 M | |||
Debt To Equity | 1.08 % | |||
Current Ratio | 3.56 X | |||
Book Value Per Share | 1.65 X | |||
Cash Flow From Operations | (93.78 M) | |||
Earnings Per Share | (1.19) X | |||
Number Of Employees | 148 | |||
Beta | 0.43 | |||
Market Capitalization | 434.89 M | |||
Total Asset | 369.83 M | |||
Retained Earnings | (104 M) | |||
Working Capital | 41 M | |||
Current Asset | 61 M | |||
Current Liabilities | 20 M | |||
Z Score | 1.8 | |||
Net Asset | 369.83 M |
About Biomm SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomm SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomm SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomm SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.It offers AFREZZA, a human insulin inhalation powder CONFORT CARE, a moisturizing foot cream GLARGILIN, a glargine insulin and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in So Paulo, Brazil. BIOMM ON operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 94 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biomm Stock Analysis
When running Biomm SA's price analysis, check to measure Biomm SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomm SA is operating at the current time. Most of Biomm SA's value examination focuses on studying past and present price action to predict the probability of Biomm SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomm SA's price. Additionally, you may evaluate how the addition of Biomm SA to your portfolios can decrease your overall portfolio volatility.